521 results
Immunization Academy
This video was developed by the Immunization Academy for use both in and outside of Tanzania.
MoH Tanzania
Tire cover communication material for HPV vaccination program in Tanzania
MoH Tanzania
Advocacy, communication and social mobilization communication plan for HPV vaccine introduction in Tanzania
MoH Tanzania
Tanzania rolling advocacy, communication, and social mobilization strategy. (DRAFT)
MoH Zimbabwe
Communication materials developed for cohort 1 and cohort 2. Also available in Shona and Ndebele.
MoH Zimbabwe
Communication materials developed for cohort 1 and cohort 2. Also available in Shona and Ndebele.
MoH Zimbabwe
Communication materials developed for cohort 1 and cohort 2. Shona and Ndebele versions also available.
MoH Tanzania
Tanzania Routine Immunization health facility register including HPV vaccine
MoH Zimbabwe
Daily tally sheet used for multi-age cohort 1 (2018 campaign)
MoH Tanzania
Tanzania's Roll Out Plan identifies responsible EPI person and technical partner, deliverables, and timeline for main HPV vaccine introduction activities.
MoH Tanzania
HPV vaccine and IPV introduction training were combined as they were being introduced simultaneously.
MoH Tanzania
Tools used for microplanning for HPV vaccine introduction
MoH Tanzania
HPV vaccine introduction training and microplanning slides. HPV vaccine and IPV introduction training were combined as they were being introduced simultaneously. The slide decks included are those...
Ministry of Health Zimbabwe
Field guide for vaccinators and teachers for HPV vaccine introduction in Zimbabwe
Ministry of Health Zimbabwe
Training agenda used in Kwekwe district as part of HPV vaccine introduction.
MoH Zimbabwe
Questionnaires used for readiness assessment prior to national HPV vaccine introduction in Zimbabwe.
MoH Senegal
Communication Material for HPV vaccination program in Senegal
World Health Organization (WHO)
The 42nd Global Advisory Committee on Vaccine Safety (GACVS) virtual meeting in May 2020 addressed pharmacovigilance preparedness for the launch of the future COVID-19 vaccines. One of their...
World Health Organization (WHO)
To support national immunization programme managers to optimize the introduction and implementation of influenza immunization programmes in countries, WHO has developed the Influenza Post...
World Health Organization (WHO)
The WHO vaccine market intelligence database compiles vaccine purchase (product, price and procurement) data as reported by countries via the WHO/UNICEF Joint Reporting Form (JRF) over the period...
World Health Organization (WHO)
This study provides the most updated understanding of current and future global trends and drivers of supply and demand for HPV vaccine. It also identifies actions to help address the current and...
World Health Organization (WHO)
This document brings together a range of resources to provide an overview of the global policies, potential interventions and strategies related to the integration of immunization services. It also...
Brenda Corcoran, Anna Clarke, Tom Barrett
The human papillomavirus (HPV) vaccination school-based programme for girls aged 12–13 years began in Ireland in 2010. Initially, the proportion of students who completed the vaccination course was...
World Health Organization (WHO)
WHO website for NUVI - Resources for monitoring and surveillance.
World Health Organization (WHO)
This essential resource document reviews the principles and issues to be considered when making decisions about planning and implementing the introduction of a vaccine into a national immunization...
World Health Organization (WHO)
With the previous edition of Immunization in Practice (IIP) having been translated and used throughout the world, we realized the tremendous responsibility we had when we embarked on this new...
UNICEF, World Health Organization (WHO)
This Facts Sheet informs of the availability of Measles vaccine and combined Measles-Rubella (MR) vaccine in both a 10-dose vial and a 5-dose vial presentations through (or via) UNICEF procurement.
Rachael M.Porter et al.
Vaccination with Human Papillomavirus (HPV) vaccine is recommended for 11–12 years-old, but uptake is suboptimal. Current messaging focuses on HPV infection transmission and prevention. Parents...
Teshome S et al.
Shanchol™, a WHO-prequalified oral cholera vaccine (OCV), has been used to control endemic cholera in Asia, as well as in emergencies and outbreaks elsewhere. The vaccine has not been used by...
Roger I.Glass et al.
Live oral rotavirus (RV) vaccines used worldwide are most effective in reducing diarrheal hospitalizations from RV in high income countries and least effective in low income countries where RV...
De Oliveira et al.
To summarize and critically evaluate the evidence on the impact and effectiveness of meningococcal vaccination programs around the world in order to inform decision-making in Latin America and the...
De la Hoz Restrepo et al.
Three highly effective vaccines are available to prevent human papillomavirus (HPV) infection, and they have been introduced in many countries around the world. This article describes advances and...
Anika Singanayagam, Maria Zambon, Ajit Lalvani, Wendy Barclay
Conflicting reports have emerged about the effectiveness of the live attenuated influenza vaccine. The live attenuated influenza vaccine appears to protect particularly poorly against currently...
KinleyDorji et al.
Background: Due to competing health priorities and limited resources, many low-income countries, even those with a high disease burden, are not able to introduce pneumococcal conjugate vaccines....
Laure Dumolard et al.
Infections due to hepatitis B virus (HBV) are a leading cause of death worldwide. WHO estimated that in 2015, 257 million people globally were living with chronic HBV infection and that 887 000...
Marc Poncin et al.
Objective To describe the implementation and feasibility of an innovative mass vaccination strategy – based on single-dose oral cholera vaccine – to curb a cholera epidemic in a large urban...
Steve Ahuka-Mundeke et al.
BACKGROUND: In 2016, the response to a yellow fever outbreak in Angola and the Democratic Republic of Congo led to a global shortage of yellow fever vaccine. As a result, a fractional dose of the...
DidierClénet
Due to their thermosensitivity, most vaccines must be kept refrigerated from production to use. To successfully carry out global immunization programs, ensuring the stability of vaccines is crucial....
Donata Medaglini et al.
A clear vision for vaccines research and development (R&D) is needed if Europe is to continue to lead the discovery of next generation vaccines. Innovation Partnership for a Roadmap on Vaccines in...
Kayvon Modjarrad et al.
Background: A safe, effective, and rapidly scalable vaccine against Zika virus infection is needed. We developed a purified formalin-inactivated Zika virus vaccine (ZPIV) candidate that showed...
Martin R Gaudinski et al.
Background: The Zika virus epidemic and associated congenital infections have prompted rapid vaccine development. We assessed two new DNA vaccines expressing premembrane and envelope Zika virus...
Objective: The objective was to investigate how state level strategies in South Carolina could maximize HPV vaccine uptake. Design: An environmental scan identified barriers, facilitators, and...
Siff Malue Nielsen et al.
This field guide prepares you to conduct qualitative formative research using focus group discussions and individual in-depth interviews. The insights you gather about your audience will help you...
Clarissa R Damaso
In 1796, Edward Jenner developed the smallpox vaccine consisting of pustular material obtained from lesions on cows affected by so-called cow-pox. The disease, caused by cowpox virus, confers...
Burke RM et al.
BACKGROUND: Rotavirus vaccines are less effective in developing countries versus developed countries. One hypothesis for this difference in performance is that higher levels of maternal antibodies in...
Pieter T. de Boer et al.
Background: To inform national healthcare authorities whether quadrivalent influenza vaccines (QIVs) provide better value for money than trivalent influenza vaccines (TIVs), we assessed the...
International Vaccine Access Center (IVAC)
Each year, IVAC prepares the Pneumonia and Diarrhea Progress Report and publishes it for World Pneumonia Day on November 12. The report evaluates the annual progress made in prevention and control of...
Stitz L et al.
Although effective rabies virus vaccines have been existing for decades, each year, rabies virus infections still cause around 50.000 fatalities worldwide. Most of these cases occur in developing...
Kimberly Bonner et al.
Highlights •High HPV vaccination coverage is critical for preventing cervical cancer worldwide. •School-based programs effectively deliver vaccines to adolescents attending school. •We...
Robin P.Lazarus et al.
Background: Strategies are needed to improve oral rotavirus vaccine (RV), which provides sub-optimal protection in developing countries. Probiotics and zinc supplementation could improve RV...
Wu Z et al.eng
Following publication of results from two phase-3 clinical trials in 10 countries or territories, endemic countries began licensing the first dengue vaccine in 2015. Using a published mathematical...
PamelaBravo-Alcántara et al.
New vaccines designed to prevent diseases endemic in low and middle-income countries are being introduced without prior utilization in countries with robust vaccine pharmacovigilance systems. Our aim...
Philippe De Wals et al.
Background: In Quebec, 7-valent (PCV7), 10-valent (PCV10) and 13-valent (PCV13) pneumococcal conjugate vaccines were successively used for the immunization of children according to a 2+1 doses...
Heyerdahl LW et al.
A reactive campaign using two doses of Shanchol Oral Cholera Vaccine (OCV) was implemented in 2016 in the Lake Chilwa Region (Malawi) targeting fish dependent communities. Three strategies for the...
Phillip Alexander Kittel
Background: Rotavirus is a highly contagious virus causing gastroenteritis, mostly in children under the age of 5. Since 2006, two vaccines are available in Germany. In 2013, these were included into...
Kimberley Kavanagh et al.
Background: On Sept 1, 2008, Scotland launched routine vaccination for human papillomavirus (HPV) types 16 and 18, targeted at 12–13-year-old girls, of whom 92·4% were fully vaccinated in...
LucyBreakwell et al.
Monovalent Hepatitis B vaccine (HepB) is heat stable, making it suitable for storage outside cold chain (OCC) at 37 °C for 1 month. We conducted an OCC project in the Solomon Islands to determine...
Jason M. Mwenda et al.
Rotavirus is a leading cause of severe pediatric diarrhea globally, estimated to have caused 120,000 deaths among children aged <5 years in sub-Saharan Africa in 2013 (1). In 2009, the World Health...
Tomonori Nochi et al.
Capable of inducing antigen-specific immune responses in both systemic and mucosal compartments without the use of syringe and needle, mucosal vaccination is considered ideal for the global control...
Stanley Plotkin et al.
As companies, countries, and governments consider investments in vaccine production for routine immunization and outbreak response, understanding the complexity and cost drivers associated with...
Kate L Seib
The sexually transmitted infection gonorrhoea is a global public health problem for which no vaccine is available. More than 106 million new cases of gonorrhoea are estimated to occur yearly...
Azwifarwi Mudau, Susan A Nzenze, Fatima Solomon, Cynthia G Whitney, Katherine L O’Brien, Elizabeth Zell, Shabir A Madhi, Michelle Groome, Jennifer Verani, Alane Izu
Among children younger than five years, Streptococcus pneumoniae is the leading cause of bacterial pneumonia and such pneumonia caused an estimated 411 000 deaths in 2010 and 335 000 deaths in 2015...
World Health Organization (WHO)
Recommendations on the use of HPV vaccines were issued by the WHO Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting in April 2022, and subsequently endorsed by WHO. This...
Prasad S. Kulkarni et al.
Rotavirus is the most common cause of moderate-to-severe infant diarrhoea in developing countries, resulting in enormous morbidity, mortality, and economic burden. A bovine-human reassortant...
Honggang Xue et al.
Inadvertent vaccine freezing often occurs in the cold chain and may cause damage to freeze‑sensitive vaccines. Liquid vaccines that contain aluminum salt adjuvants are particularly vulnerable....
Soleine Scotney et al.
Introducing a new vaccine is a large-scale endeavor that can face many challenges, resulting in introduction delays and inefficiencies. The development of national task teams and tools, such as...
Lynda U. Osadebe et al.
Background: Kano State, Nigeria, introduced inactivated polio vaccine (IPV) into its routine immunization (RI) schedule in March 2015 and was the pilot site for an RI data module for the National...
Samara Perez et al.
Background: HPV vaccination uptake in boys is suboptimal in many jurisdictions, particularly in the absence of publicly funded HPV vaccination programs. Parents represent key decision-makers of HPV...
Folake Olayinka et al.
The number of vaccines available to low-income countries has increased dramatically over the last decade. Overall infant immunization coverage in the WHO African region has stagnated in the past few...
Katja HöschlerEmail the author Katja Höschler & Maria C Zambon
Despite strong recommendations, influenza vaccine uptake data for the UK for 2015–16 show that actual uptake in the population targeted lags behind the goal of the national vaccine programme,1...
XiLi et al.
Hepatitis B is highly endemic in the Republic of Kiribati, while the coverage of timely birth dose vaccination, the primary method shown to prevent mother-to-child transmission of hepatitis B virus,...
U. Heininger et al.
In 2013, the Council for International Organizations of Medical Sciences (CIOMS) created a Working Group on Vaccine Safety (WG) to address unmet needs in the area of vaccine pharmacovigilance....
Natalya Nepomnyashch
As of May 2017, two medical laboratory scientists employed by the Sokoto State Government, jointly trained by the University of Nebraska Medical Centre and eHA are operating the lab. During the 2017...
Muhammad Ehsanul Hoque
In South Africa, HPV vaccination programme has been incorporated recently in the school health system. Since doctors are the most trusted people regarding health issues in general, their knowledge...
Keith P Klugman, Sharon Bergquist, Ajoke Sobanjo-ter Meulen
Although considerable progress has been made globally to reduce under-5 mortality, advances in the reduction of neonatal deaths in the first year of life have been slower. The annual deaths of almost...
William P. Hausdorffa, Steve Black
Pneumococcal conjugate vaccines have proven highly effective in decreasing invasive disease and pneumonia in young children. However, there is considerable geographic variability in the impact of...
Nicholas Luter et al.
In 1997, Milstien, Batson, and Meaney published “A Systematic Method for Evaluating the Potential Viability of Local Vaccine Producers.” The paper identified characteristics of successful vaccine...
Kaleb BrownlowEmail author & Daniel Thornton
As countries expand immunisation programmes to include new vaccines and ensure increased coverage and equity, existing and potential constraints exist within the supply chain systems to manage an...
Katherine E. Gallagher et al.
Objective: To synthesise lessons learnt and determinants of success from human papillomavirus (HPV) vaccine demonstration projects and national programmes in low- and middle-income countries...
PATH
This fact sheet describes the work and approach of the Typhoid Vaccine Acceleration Consortium (TyVAC), a partnership between the Center for Vaccine Development at the University of Maryland, the...
PATH
This fact sheet describes PATH’s efforts to eliminate meningococcal meningitis epidemics from Africa, once and for all. It covers work across meningitis projects, including the development and...
Caroline L Trotter et al.
Background: In preparation for the introduction of MenAfriVac, a meningococcal group A conjugate vaccine developed for the African meningitis belt, an enhanced meningitis surveillance network was...
Manjunath B. Shankar et al.
Background: West Nile virus (WNV) is the leading cause of domestically-acquired arboviral disease in the United States. Several WNV vaccines are in various stages of development. We estimate the...
Melissa Berman et al.
Background: In children, the 13 and 10-valent pneumoccocal conjugate vaccines (PCV13/10) are currently approved for the prevention of invasive pneumococcal disease (IPD). Acceptability is a key...
Mohammad Ali et al.
Background: Pregnancy increases the risk of harmful effects from cholera for both mothers and their fetuses. A killed oral cholera vaccine, Shanchol (Shantha Biotechnics, Hydrabad, India), can...
Xiao Xian Huang et al.
Objective: At the end of 2013, a pilot experiment was carried out in Comé health zone (HZ) in an attempt to optimize the vaccine supply chain. Four commune vaccine storage facilities were replaced...